As underlined in other reports [23,24,25], it remains hard to distinguish whether enhanced baseline CRP levels are merely the reflection of systemic inflammation associated to risk factors of primary ACS disease diagnosis, such as gender, ageing, obesity, and diabetes, or if it plays an active role in disease progression. Here, CRP is linked to obesity due to melanocortin 4 receptor deficiency.